Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
Chicago Atlantic Real Estate Finance Inc
NASDAQ:REFI
|
US |
Multiples-Based Value
The Multiples-Based Value for
Regeneron Pharmaceuticals Inc (REGN) under the Base Case is 736.446 USD.
Compared with the current market price of 756.035 USD, the stock appears
Overvalued by 3% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.